PerpEquities

Bristol Myers Squibb (BMY) balance sheet

NYSE · Healthcare · Drug Manufacturers - General · 32,500 employees · CEO Christopher Boerner

Price
$62.48 +1.78%
Market cap
$128B
Enterprise value
$163B
Last report
Q3 '26 filed 2026-10-29
Next report
2027-02-04 EPS est. $1.52

At the end of Q3 '26 Bristol Myers Squibb (BMY) held $12.6B in cash and short-term investments against $44.8B of debt incl. leases. Total assets $88.8B, total liabilities $65.4B, shareholders' equity $23.4B.

Balance sheet

Balance sheetTrendQ4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Assets
Cash & equivalents$11.5B$9.33B$6.29B$7.89B$10.3B$10.9B$12.6B$15.7B$10.2B$9.57B$8.72B$9.57B
Short-term investments$816M$340M$360M$204M$513M$907M$1B$776M$464M$912M$2.35B$3.01B
Receivables$15.3B$14.1B$15.1B$14.9B$14.4B$14.6B$15.1B$14.6B$14.5B$12.1B$10.6B$10.6B
Inventory$2.66B$2.99B$3.08B$3.33B$2.56B$2.67B$2.74B$2.76B$2.69B$2.76B$2.74B$2.7B
Other current assets$1.56B$1.95B$2.01B$1.75B$1.94B$1.75B$1.78B$1.75B$1.5B$1.88B$4.22B$3.84B
Current assets$31.8B$28.7B$26.9B$28.1B$29.8B$30.8B$33.2B$35.6B$29.4B$27.2B$28.6B$29.8B
Property, plant & equipment (net)$8.04B$8.19B$8.16B$8.25B$8.36B$8.43B$8.65B$7.35B$9.13B$9.19B$7.79B$7.97B
Long-term investments$2.5B$2.89B$3B$2.85B$2.51B$2.25B$2.25B$2.36B$2.51B$2.24B$397M$378M
Goodwill$21.2B$21.7B$21.7B$21.8B$21.7B$21.7B$21.8B$21.7B$21.8B$21.7B$21.7B$21.7B
Intangible assets$27.5B$33.2B$29.8B$27.3B$23.6B$22.8B$21.7B$20.5B$19.4B$18.5B$17.4B$16.9B
Deferred tax assets$2.77B$2.72B$3.32B$3.61B$4.24B$4B$4.65B$4.96B$5.38B$5.18B$5.36B$5.88B
Other non-current assets$1.43B$1.66B$1.7B$1.8B$2.36B$2.43B$2.47B$4.38B$2.53B$2.43B$6.38B$6.1B
Non-current assets$63.4B$70.4B$67.8B$65.6B$62.8B$61.6B$61.5B$61.3B$60.6B$59.3B$59.1B$59B
Total assets$95.2B$99B$94.6B$93.7B$92.6B$92.4B$94.7B$96.9B$90B$86.5B$87.6B$88.8B
Liabilities
Accounts payable$3.26B$3.54B$3.75B$3.47B$3.6B$4B$5.43B$4.29B$3.58B$4.23B$4.16B$4.63B
Accrued expenses$349M$546M$591M$512M$572M$516M$575M$512M$484M$507M$0$0
Short-term debt$3.12B$6.19B$3.53B$1.08B$2.05B$3.55B$4.72B$4.51B$2.26B$2.31B$1.03B$1.25B
Taxes payable$1.37B$1.49B$1.47B$1.49B$1.51B$1.45B$0$0$0$0$0$0
Other current liabilities$12.8B$12.7B$12.5B$14.7B$14.6B$13.1B$14.4B$16.3B$14.6B$9.72B$13.5B$12.9B
Current liabilities$22.3B$25.8B$23.3B$22.6B$23.8B$24.1B$27.5B$28.1B$23.4B$19.2B$18.7B$18.8B
Long-term debt$36.7B$49.5B$48.9B$48.7B$47.6B$46.2B$44.5B$44.5B$42.9B$42.2B$42.1B$41.8B
Lease obligations (non-current)$1.53B$1.56B$1.44B$1.48B$1.37B$1.36B$1.55B$1.85B$1.83B$1.77B$0$1.71B
Deferred revenue (non-current)$300M$282M$263M$247M$230M$213M$197M$180M$169M$155M$0$128M
Deferred tax liabilities$338M$442M$461M$430M$369M$276M$247M$225M$222M$211M$222M$228M
Other non-current liabilities$4.59B$4.89B$3.29B$3B$2.87B$2.91B$3.2B$3.43B$3.05B$2.93B$4.34B$2.7B
Non-current liabilities$43.4B$56.7B$54.3B$53.8B$52.4B$50.9B$49.7B$50.2B$48.1B$47.2B$46.7B$46.6B
Total liabilities$65.7B$82.5B$77.6B$76.5B$76.2B$75B$77.2B$78.3B$71.5B$66.4B$65.3B$65.4B
Equity
Common stock & paid-in capital$292M$292M$292M$292M$292M$292M$292M$292M$292M$292M$292M$292M
Retained earnings$28.8B$15.6B$16.1B$16.1B$14.9B$16.1B$16.2B$17.1B$16.9B$18.3B$20.3B$21.2B
Accumulated other comprehensive income-$1.55B-$1.4B-$1.46B-$1.47B-$1.24B-$1.42B-$1.55B-$1.51B-$1.52B-$1.37B-$1.29B-$1.28B
Shareholders' equity$29.4B$16.5B$17B$17.1B$16.3B$17.4B$17.4B$18.6B$18.5B$20.1B$22.3B$23.4B
Debt
Total debt (incl. leases)$41.5B$57.4B$54B$51.4B$51.2B$51.2B$50.9B$51B$47.1B$46.4B$43.1B$44.8B
Net debt (debt - cash)$30B$48.1B$47.7B$43.5B$40.9B$40.4B$38.3B$35.3B$36.9B$36.9B$34.4B$35.2B

Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30

Data as of 2026-11-01